Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teruhiko Miyazaki

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 13, 2009
[A-TOP research group/JOINT program]Tatsuhiko Kuroda, Nobuaki Miyakawa, Teruhiko Miyazaki, et al.
Calcified Tissue International|July 27, 2015
Impact of Osteonecrosis of the Jaw on Osteoporosis Treatment in Japan: Results of a Questionnaire-Based Survey by the Adequate Treatment of Osteoporosis (A-TOP) Research GroupAkira Taguchi, Masataka Shiraki, Mayumi Tsukiyama, et al.
Journal of Bone and Mineral Metabolism|July 19, 2018
Study design of multi-center, open-label randomized controlled, head-to-head trial comparing minodronic acid and raloxifene: Japanese Osteoporosis Intervention Trial (JOINT)-04Yukari Uemura, Shiro Tanaka, Teruhiko Miyazaki, et al.
Current Medical Research and Opinion|September 2, 2020
Randomized head-to-head comparison of minodronic acid and raloxifene for fracture incidence in postmenopausal Japanese women: the Japanese Osteoporosis Intervention Trial (JOINT)-04Yukari Uemura, Teruki Sone, Shiro Tanaka, et al.
Journal of Bone and Mineral Metabolism|August 4, 2016
Comparison of concurrent treatment with vitamin K<sub>2</sub> and risedronate compared with treatment with risedronate alone in patients with osteoporosis: Japanese Osteoporosis Intervention Trial-03Shiro Tanaka, Teruhiko Miyazaki, Yukari Uemura, et al.
Journal of Bone and Mineral Metabolism|July 6, 2013
Design of a randomized clinical trial of concurrent treatment with vitamin K2 and risedronate compared to risedronate alone in osteoporotic patients: Japanese Osteoporosis Intervention Trial-03 (JOINT-03)Shiro Tanaka, Teruhiko Miyazaki, Yukari Uemura, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 13, 2009
[A-TOP research group/JOINT program]Tatsuhiko Kuroda, Nobuaki Miyakawa, Teruhiko Miyazaki, et al.
Calcified Tissue International|July 27, 2015
Impact of Osteonecrosis of the Jaw on Osteoporosis Treatment in Japan: Results of a Questionnaire-Based Survey by the Adequate Treatment of Osteoporosis (A-TOP) Research GroupAkira Taguchi, Masataka Shiraki, Mayumi Tsukiyama, et al.
Journal of Bone and Mineral Metabolism|July 19, 2018
Study design of multi-center, open-label randomized controlled, head-to-head trial comparing minodronic acid and raloxifene: Japanese Osteoporosis Intervention Trial (JOINT)-04Yukari Uemura, Shiro Tanaka, Teruhiko Miyazaki, et al.
Current Medical Research and Opinion|September 2, 2020
Randomized head-to-head comparison of minodronic acid and raloxifene for fracture incidence in postmenopausal Japanese women: the Japanese Osteoporosis Intervention Trial (JOINT)-04Yukari Uemura, Teruki Sone, Shiro Tanaka, et al.
Journal of Bone and Mineral Metabolism|August 4, 2016
Comparison of concurrent treatment with vitamin K<sub>2</sub> and risedronate compared with treatment with risedronate alone in patients with osteoporosis: Japanese Osteoporosis Intervention Trial-03Shiro Tanaka, Teruhiko Miyazaki, Yukari Uemura, et al.
Journal of Bone and Mineral Metabolism|July 6, 2013
Design of a randomized clinical trial of concurrent treatment with vitamin K2 and risedronate compared to risedronate alone in osteoporotic patients: Japanese Osteoporosis Intervention Trial-03 (JOINT-03)Shiro Tanaka, Teruhiko Miyazaki, Yukari Uemura, et al.
Pageof 1